Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-26-005836
Filing Date
2026-07-29
Accepted
2026-07-29 16:58:37
Documents
85
Period of Report
2026-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR APRIL 2026 pharmacyte_i10k-043026.htm   iXBRL 10-K 2185015
2 CORPORATE BYLAWS, AS AMENDED pharmacyte_ex0306.htm EX-3.6 131130
3 LIST OF SUBSIDIARIES pharmacyte_ex2101.htm EX-21.1 1854
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM pharmacyte_ex2301.htm EX-23.1 3864
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER pharmacyte_ex3101.htm EX-31.1 9037
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER pharmacyte_ex3102.htm EX-31.2 9064
7 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 4473
8 CERTIFICATION pharmacyte_ex3202.htm EX-32.2 4496
14 GRAPHIC image_001.jpg GRAPHIC 3011
15 GRAPHIC image_002.jpg GRAPHIC 1292
16 GRAPHIC image_003.jpg GRAPHIC 2802
17 GRAPHIC image_004.jpg GRAPHIC 2855
  Complete submission text file 0001683168-26-005836.txt   9354245

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE pmcb-20260430.xsd EX-101.SCH 69677
10 XBRL CALCULATION FILE pmcb-20260430_cal.xml EX-101.CAL 81410
11 XBRL DEFINITION FILE pmcb-20260430_def.xml EX-101.DEF 326626
12 XBRL LABEL FILE pmcb-20260430_lab.xml EX-101.LAB 566596
13 XBRL PRESENTATION FILE pmcb-20260430_pre.xml EX-101.PRE 479917
89 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_i10k-043026_htm.xml XML 1105700
Mailing Address 3960 HOWARD HUGHES PARKWAY SUITE 500 LAS VEGAS NV 89169
Business Address 3960 HOWARD HUGHES PARKWAY SUITE 500 LAS VEGAS NV 89169 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-40699 | Film No.: 261218675
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)